These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8880059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T, Fujimura A, Shiga T, Sasaki M, Harada K, Tateishi T, Ohashi K, Ebihara A.
    Eur J Clin Pharmacol; 1994; 46(3):267-9. PubMed ID: 8070509
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H, Böttcher MF, Ochmann K.
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [Abstract] [Full Text] [Related]

  • 5. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP.
    Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA, Schultz RW, Schentag JJ.
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2364-8. PubMed ID: 2088191
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM, Hoepelman AI, Smit JM, Sips PA, Rozenberg-Arska M, Glerum JH, Verhoef J.
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2458-61. PubMed ID: 1336948
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
    Lebrec D, Gaudin C, Benhamou JP.
    Am J Med; 1992 Apr 06; 92(4A):41S-44S. PubMed ID: 1316069
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
    Stuht H, Lode H, Koeppe P, Rost KL, Schaberg T.
    Antimicrob Agents Chemother; 1995 May 06; 39(5):1045-9. PubMed ID: 7625786
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and safety of single oral doses of lomefloxacin.
    Morse IS.
    Biopharm Drug Dispos; 1990 May 06; 11(6):543-51. PubMed ID: 2207304
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.
    Kozawa O, Uematsu T, Matsuno H, Niwa M, Nagashima S, Kanamaru M.
    Antimicrob Agents Chemother; 1996 Dec 06; 40(12):2824-8. PubMed ID: 9124849
    [Abstract] [Full Text] [Related]

  • 18. Differential-pulse adsorptive stripping voltammetric determination of the antibacterial lomefloxacin.
    Vílchez JL, Araujo L, Prieto A, Navalón A.
    J Pharm Biomed Anal; 2001 Aug 06; 26(1):23-9. PubMed ID: 11451639
    [Abstract] [Full Text] [Related]

  • 19. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
    Wijnands GJ, Cornel JH, Martea M, Vree TB.
    Chest; 1990 Dec 06; 98(6):1440-4. PubMed ID: 2245687
    [Abstract] [Full Text] [Related]

  • 20. The effect of histamine-2 receptor antagonists on tocainide pharmacokinetics.
    North DS, Mattern AL, Kapil RP, Lalonde RL.
    J Clin Pharmacol; 1988 Jul 06; 28(7):640-3. PubMed ID: 2905709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.